Please ensure Javascript is enabled for purposes of website accessibility U.S. Financial Professionals | Janus Henderson Investors

Kardashians and tails

Ten years ago the reality TV family – the Kardashians – came into our lives, just as the S&P 500 reached its pre-financial crisis peak. ​Aneet Chachra, portfolio manager in the Diversified Alternatives team at Janus Henderson, takes a look at fat-tail events and the potential value within the options market.

Square root recovery

John Pattullo | Janus Henderson Investors

​A decade on from the Global Financial Crisis, economic recovery has turned out to be both one of the weakest, and the longest, in modern history. John Pattullo, Co- Head of Strategic Fixed Income, shares his views on economic growth since the downturn, and into the future.

Alternative to What?

Alternative To What | Janus Henderson Investors

Alternatives can play an important role in a portfolio, but do you know exactly what that role is?

Essentials: Global Equities Strategy

Ian Warmerdam | Janus Henderson Investors

In this ‘Essentials video’, Ian Warmerdam, Head of the UK-based Global Equities Team, and Portfolio Managers Ronan Kelleher, Steve Weeple and Gordon Mackay, provide an introduction to the strategy they manage in Edinburgh, including a team overview, their investment approach and objective, key differentiators and why investors should consider an actively-managed approach to investing in

Essentials: Fixed Interest Monthly Income Fund

In this ‘Essentials’ video, Nicholas Ware, Director of Retail Fixed Income, provides an overview of the Henderson Fixed Interest Monthly Income Fund, including the fund’s strategy, differentiators and the approach of the investment team.

Are You “Active” in LDI?

Are You “Active” in LDI? | Janus Henderson Investors

Active long-credit may offer a superior solution to hedge pension liabilities – navigating ratings migrations to mitigate downside risk and uncover opportunity.

A shot in the arm for the UK life sciences industry?

The UK government recently revealed its ambitious Life Sciences Industrial Strategy and pledged £146m to support health care-related projects. In this Q&A, Ethan Lovell, co-portfolio manager of the Janus Henderson Global Life Sciences Strategy, provides his take on these initiatives.